Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes
Arwa Alkaraki, Walhan Alshaer, Suha Wehaibi, Lobna Gharaibeh, Duaa Abuarqoub, Dana A. Alqudah, Hafsa Al-Azzawi, Hadil Zureigat, Mamoun Souleiman, Abdalla Awidi
Topics & Concepts
DoxorubicinGene silencingCD44Cancer researchTriple-negative breast cancerCancer cellCancerMedicineBiologyBreast cancerMolecular biologyCellChemotherapyInternal medicineGeneGeneticsCytokine Signaling Pathways and InteractionsCancer-related Molecular PathwaysMicroRNA in disease regulation